AK Medical Holdings Limited reported the repurchase of 100,000 ordinary shares on 2 October 2026 at HK$4.67 per share, bringing the total consideration to HK$0.47 million. The transaction was conducted on The Stock Exchange of Hong Kong under the general mandate approved on 17 June 2026, which authorises the company to buy back up to 112.46 million shares.

Following the buyback, AK Medical’s issued share capital (excluding treasury shares) decreased marginally by 0.0093 % to 1.08 billion shares. Concurrently, the company’s treasury stock rose to 32.94 million shares. The overall number of issued shares, including treasury shares, remained unchanged at 1.11 billion.

Cumulatively, AK Medical has repurchased 48.51 million shares under the current mandate, representing 4.31 % of the issued shares outstanding as at the mandate date. In line with Hong Kong Stock Exchange rules, the company is now subject to a moratorium on new share issues or further treasury share sales until 1 November 2026.